Predictors of Healthcare Utilization in Newly Diagnosed Myeloma

Introduction The introduction of novel therapies has significantly improved outcomes in myeloma. However, the economic burden of enhanced healthcare utilization is significant and cannot be discounted. This study sought to identify baseline characteristics that may influence outcomes and subsequent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2020-11, Vol.136 (Supplement 1), p.37-38
Hauptverfasser: Toolan, Shane, Griffin, Mark, Coyne, Mark, O'Mahony, Kate, Lewis, Joy, D'Souza, Chandan, Connaghan, Daniel G, Murphy, Karen, Fadalla, Kamal, Fitzgerald, Joan Marie, Collins, Conor, Swan, Niall, Tom, Crotty, David, Gibbons, Smyth, Liam
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!